Sudden death after sustained restraint following self-administration of the designer drug α-pyrrolidinovalerophenone.
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Hisashi
H
Nagai
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Kanju
K
Saka
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Makoto
M
Nakajima
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Hidyuki
H
Maeda
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Ryohei
R
Kuroda
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Atsuko
A
Igarashi
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Takako
T
Tsujimura-Ito
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Akina
A
Nara
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan.
Masatomo
M
Komori
Department of Forensic Medicine, Graduate School of Medicine, The University of Tokyo, Japan. Electronic address: kyoshida@m.u-tokyo.ac.jp.
Ken-Ichi
K
Yoshida
D000328:Adult; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D015198:Designer Drugs / Q000009:adverse effects*; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D011759:Pyrrolidines / Q000009:adverse effects*; D012149:Restraint, Physical / Q000009:adverse effects*; D012646:Self Administration
D015198:Designer Drugs; D011759:Pyrrolidines; C542924:alpha-pyrrolidinovalerophenone
Heart failure; Restraint; Stimulant; Stress; Sudden cardiac death; α-Pyrrolidinovalerophenone (α-PVP)